These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15286086)

  • 1. Pharmacological and clinical profile of moexipril: a concise review.
    Chrysant SG; Chrysant GS
    J Clin Pharmacol; 2004 Aug; 44(8):827-36. PubMed ID: 15286086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile and clinical use of moexipril.
    Chrysant SG; Chrysant GS
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):345-52. PubMed ID: 15030263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension.
    White WB; Koch B; Stimpel M
    Am J Ther; 1997 Apr; 4(4):123-9. PubMed ID: 10423601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moexipril. A review of its use in the management of essential hypertension.
    Brogden RN; Wiseman LR
    Drugs; 1998 Jun; 55(6):845-60. PubMed ID: 9617599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats.
    Ma YF; Stimpel M; Liang H; Pun S; Jee WS
    J Endocrinol; 1997 Sep; 154(3):467-74. PubMed ID: 9379124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).
    Stimpel M; Koch B; Oparil S
    Cardiology; 1998 May; 89(4):271-6. PubMed ID: 9643274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effectiveness of a very low fixed-dose combination of moexipril and hydrochlorothiazide.
    Chrysant SG; Stimpel M
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):384-90. PubMed ID: 9514183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension.
    White WB; Stimpel M
    J Hum Hypertens; 1995 Nov; 9(11):879-84. PubMed ID: 8583466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.
    Persson B; Stimpel M
    Eur J Clin Pharmacol; 1996; 50(4):259-64. PubMed ID: 8803515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical safety studies of the combination moexipril hydrochloride/hydrochlorothiazide.
    Gietl R; Friehe H; Ney P
    Arzneimittelforschung; 1998 Apr; 48(4):365-70. PubMed ID: 9608878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the antihypertensive effectiveness of a combination of moexipril or sustained-release verapamil with low-dose hydrochlorothiazide.
    Chrysant SG; Stimpel M
    J Clin Pharmacol; 1996 Aug; 36(8):701-6. PubMed ID: 8877673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial.
    Spinar J; Vítovec J;
    Int J Cardiol; 2005 Apr; 100(2):199-206. PubMed ID: 15823625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.
    White WB; Whelton A; Fox AA; Stimpel M; Kaihlanen PM
    J Clin Pharmacol; 1995 Mar; 35(3):233-8. PubMed ID: 7608310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide.
    Hutt V; Michaelis K; Verbesselt R; De Schepper PJ; Salomon P; Bonn R; Cawello W; Angehrn JC
    Eur J Clin Pharmacol; 1996; 51(3-4):339-44. PubMed ID: 9010710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control.
    Pines A; Fisman EZ
    Am J Cardiovasc Drugs; 2003; 3(5):351-60. PubMed ID: 14728069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.